Venus Remedies Adjusts Valuation Amid Mixed Technical Signals and Financial Growth
Venus Remedies, a microcap in the Pharmaceuticals & Biotechnology sector, has recently adjusted its evaluation, reflecting changes in financial metrics and market position. The stock's valuation grade has shifted, influenced by its PE ratio and price-to-book value, while technical trends indicate a period of stability. The company has shown positive financial performance with growth in operating profit and net sales, supported by a low debt-to-equity ratio.
Venus Remedies, a microcap player in the Pharmaceuticals & Biotechnology sector, has recently undergone an evaluation adjustment that reflects changes in its underlying financial metrics and market position. The stock's score has been revised, indicating a shift in its valuation grade from attractive to fair. This adjustment is influenced by various financial indicators, including a PE ratio of 17.31 and a price-to-book value of 0.95, which suggest a more balanced assessment of the company's market standing.In terms of technical trends, the stock has transitioned from a mildly bearish outlook to a sideways trend, indicating a period of stability without clear momentum. Key technical indicators such as the MACD and Bollinger Bands present mixed signals, with some metrics showing bullish tendencies while others remain neutral.
Venus Remedies has demonstrated positive financial performance in its latest quarter, with significant growth in operating profit and net sales. The company maintains a low debt-to-equity ratio, which supports its financial health. Overall, the recent evaluation adjustment reflects a nuanced view of Venus Remedies' current market position and financial metrics.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
